06:51 EDT Eli Lilly to acquire Morphic for $57 per share in cash
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LLY:
- Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease
- Ozempic shown in JAMA study to lower obesity-associated cancer risk
- Eli Lilly call volume above normal and directionally bullish
- Morgan Stanley says impact to Lilly GLP-1 opportunity from NAION link ‘very low’
- BMO: Eli Lilly’s (NYSE:LLY) Alzheimer’s Drug Could Boost Sales by $7.1B
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue